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Protocol
AbstrACt
Introduction Surgical site infections (SSIs) are a significant 
cause of morbidity and mortality in low-income and middle-
income countries, where rates of SSIs can reach 30%. Due 
to limited access, there is minimal follow-up postoperatively. 
Community health workers (CHWs) have not yet been used 
for surgical patients in most settings. Advancements in 
telecommunication create an opportunity for mobile health 
(mHealth) tools to support CHWs. We aim to evaluate the use 
of mHealth technology to aid CHWs in identification of SSIs 
and promote referral of patients back to healthcare facilities.
Methods and analysis Prospective randomised controlled 
trial conducted at Kirehe District Hospital, Rwanda, from 
November 2017 to November 2018. Patients ≥18 years who 
undergo caesarean section are eligible. Non-residents of 
Kirehe District or patients who remain in hospital >10 days 
postoperatively will be excluded. Patients will be randomised 
to one of three arms. For arm 1, a CHW will visit the patient’s 
home on postoperative day 10 (±3 days) to administer an SSI 
screening protocol (fever, pain or purulent drainage) using 
an electronic tablet. For arm 2, the CHW will administer the 
screening protocol over the phone. For both arms 1 and 2, 
the CHW will refer patients who respond ‘yes’ to any of the 
questions to a health facility. For arm 3, patients will not 
receive follow-up care. Our primary outcome will be the 
impact of the mHealth-CHW intervention on the rate of return 
to care for patients with an SSI.
Ethics and dissemination The study has received ethical 
approval from the Rwandan National Ethics Committee and 
Partners Healthcare. Results will be disseminated to Kirehe 
District Hospital, Rwanda Ministry of Health, Rwanda Surgical 
Society, Partners In Health, through conferences and peer-
reviewed publications.
trial registration number NCT03311399.
IntroduCtIon 
background
Surgical site infections (SSIs) are a major 
source of morbidity and mortality world-
wide and the leading healthcare-associated 
infection in the low-income and middle-in-
coume countries (LMICs).1 The burden is 
disproportionately felt in LMICs, and espe-
cially by those in Africa where the rates of 
postoperative SSIs have been documented 
as high as 30.9%.2 In these settings, SSIs 
often develop after patients are discharged 
home, and geographic and resource barriers 
prevent patients from routine postopera-
tive follow-up.3 4 In many LMICs, including 
Rwanda, follow-up with a surgical care 
provider after a procedure is not routine. Even 
when scheduled, rates of follow-up are low. A 
study from Central African Republic reported 
only 25% of surgical patients returned for 
strengths and limitations of this study
 ► The greatest strength is that this is a prospective 
randomised controlled trial to most effectively eval-
uate the impact of a mobile health and community 
health worker (CHW) intervention on return to care 
following surgery.
 ► The screening protocol used has been previously 
validated by the study team in this setting.
 ► The study is well-resourced with significant on the 
ground logistical support through Partners In Health 
and the staff at Kirehe District Hospital.
 ► In addition to assessing the impact on patient re-
turn-to-care behaviours, this study will also allow 
us to describe the feasibility of mobile  health and 
CHW interventions in this setting, beyond surgical 
interventions.
 ► Since validating the presence or absence of post-
operative infections would interfere with the study 
aims, we can only compare the proportion of all pa-
tients that return to care with confirmed infections 
and must assume that the infection rates across 
arms are constant.
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their scheduled 30-day postoperative visit.5 For patients 
who develop an SSI, failure to return or a delayed return 
to care is linked with poor health outcomes including 
sepsis, need for reoperation, death and increased health-
care costs.6 
In many LMICs, community health workers (CHWs) 
play a major role in delivering household-based care to 
vulnerable populations who might otherwise be unable to 
access health facilities.7 8 Globally, the range of responsi-
bilities of CHWs vary by programme, whether polyvalent 
or topic-focused, such as the maternal and child health 
CHWs in Rwanda.9 Regardless of the range, the number 
of responsibilities is typically high leading to CHW 
work overload. Additional activities require extensive 
preservice or postservice training or provision of activity 
support aides. Recent advances in telecommunication 
and increasing access to mobile phones in LMICs create 
opportunities to use mobile health (mHealth) strategies 
to support CHWs. In Rwanda, 63% of the population in 
2014 reportedly owned a cell phone, with 99% having 
access to mobile networks.10 Multiple studies have shown 
that real-time use of mHealth technologies increases 
adherence to health protocols in rural Africa,11–15 and 
also improves the perceived quality of care.16
In 2014, members of the study team carried out a pilot 
study in Haiti that involved CHWs following up with 
surgical patients once discharged and evaluating their 
wounds for an SSI.17 The CHWs used an mHealth appli-
cation that prompted the CHW to evaluate the wound for 
certain characteristics pertaining to SSIs as well as to take 
a photograph of the wound. The CHW’s assessment of 
the wounds were then compared with a surgeon’s assess-
ment (using the photograph), and found 85% agree-
ment. In the phase I study precluding this manuscript, 
over a 4-month period in 2017 (March– July) at KDH, we 
evaluated caesarean section (C-section) patients at post-
operative day (POD) 10 (±3 days) and found a 10.3% SSI 
incidence (results yet to be published). In this study, we 
draw from lessons learnt in the pilot to rigorously explore 
the use of mHealth-CHW interventions for postoperative 
follow-up of patients delivering via C-sections in rural 
Rwanda.
Aims
The overall study aim is to examine whether CHWs, 
guided by an mHealth-delivered screening protocol, 
can improve the identification of SSIs and inform 
a timely return to care among patients who undergo 
C- sections.
Specific objectives:
 ► Objective 1: evaluate the impact of the mHealth-CHW 
interventions on patients returning to the health 
centre or hospital for a possible SSI.
 ► Objective 2: to assess the feasibility of an mHealth-CHW 
intervention for postoperative follow-up.
After receipt of a voluntary written consent, enrolled 
patients will be randomly assigned to one of three arms 
(figure 1):
 ► Arm 1: an mHealth-CHW intervention where the 
CHW visits the patient postoperatively, administers 
the screening protocol and refers the patient back to 
care if there is evidence of an SSI.
Figure 1 Study design. CHW, community health workers; POD, post operative day; SSI, surgical site infection.
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 ► Arm 2: an mHealth-CHW intervention where the 
CHW calls the patient postoperatively, administers 
the screening protocol over the phone and refers the 
patient back to care if there is evidence of an SSI.
 ► Arm 3: standard of care (no routine follow-up).
MEthods And AnAlysIs
study location
This study will take place between November 2017and 
November 2018 at Kirehe District Hospital (KDH), 
one of 42 district hospitals in Rwanda. KDH is a level 1 
hospital, with 235 beds, operated by the Rwanda Ministry 
of Health and supported by the medical non-profit organ-
isation Partners In Health (PIH). The hospital serves a 
catchment area of 368 950 people, primarily residing 
in rural, outlying villages. KDH performs around 1400 
surgical operations a year, with the majority being C-sec-
tions.18 Nearly all C-sections are performed by general 
practitioner (GP) physicians, with occasional surgeries 
performed by visiting obstetricians.
study population
This study will only include patients undergoing C-section 
delivery, which are the majority of patients undergoing an 
operation, at KDH. Over 60% of all surgeries performed 
at Rwandan district hospitals are obstetric related.19 All 
patients aged 18 years or older undergoing a C-section 
at KDH during a 12-month study enrolment window will 
be eligible for inclusion. Participants must be residents 
of Kirehe District. We will exclude patients who remain 
inpatient after POD 10 as the window for follow-up we 
are interested in would have passed (10 days postopera-
tive ±3 days). We will also exclude patients who are resi-
dents of Mahama refugee camp in Kirehe as the refugee 
camp is temporary and the patients are not covered by 
the existing CHW network.
the ssI screening protocol
The study SSI screening protocol will consist of three 
screening questions, which were developed and validated 
during phase I of this study. Phase I was also carried out 
at KDH, and the three questions were selected to have 
the highest sensitivity while maintaining reasonable spec-
ificity for diagnosing an SSI. The optimisation occurred 
over a 4-month period in 2017 and included post-C-sec-
tion surgical discharged patients aged 18 years or older. 
Patients returned to the hospital for evaluation on POD 
10 (±3 days) and were evaluated by a GP. A CHW admin-
istered a 10-question SSI screening protocol assessing for: 
1) increased pain since discharge; 2) fever since discharge, 
3) erythema, 4) edema, 5) induration, 6) dehiscence, 7) 
drainage from the wound, 8) drainage with discoloura-
tion, 9) drainage with a foul odour and 10) drainage with 
pus (purulent drainage). Using the GP’s SSI diagnosis 
as the gold standard, we identified the following three 
questions as most sensitive and specific for SSI diagnosis: 
purulent drainage, pain and fever (table 1).
study interventions
The study involves two different interventions: use 
of mHealth and CHWs arms. For both interventions, 
patients will be screened at POD 10 (±3 days). We selected 
this window because the majority of SSIs develop between 
POD 5 and 10 days and timely identification of SSIs is 
a critical aspect of the intervention.20 In arm 1, a CHW 
will travel to the patient’s home to evaluate the patient. 
Prior to the visit, the patient will be called to confirm 
location and time. The hired surgical CHW will contact 
the local CHW who will guide the surgical CHW to the 
patient’s home. Once at the patient’s home, the local 
CHW will leave, and the surgical CHW will evaluate the 
patient using the SSI screening protocol administered on 
an electronic tablet and take a photo of the wound. In 
arm 2, a CHW will call the patient on the phone on POD 
10 (±3 days). Three attempts will be made to reach the 
patient. The CHW will administer the screening protocol 
over the phone, prompted by the tablet application to ask 
the appropriate questions. For both intervention arms, 
if the patient answers yes to any of the three questions, 
the patient will be instructed by the CHW to present to 
the local health centre for evaluation and referral to 
KDH if necessary. Patients not identified with an SSI will 
be reminded of proper wound care, warning signs of SSI 
and to follow-up should there be any change. In arm 3, 
patients will be given discharge instructions; however, 
they will not have any contact with a CHW following 
discharge and therefore will serve as a control group.
study consent, enrolment, randomisation and follow-up
On POD 2, eligible patients will be identified. Study staff 
will read the consent form (see online supplementary 
appendix) to the patient in Kinyarwanda and solicit a 
signed consent. Once the patient is enrolled, there will 
be no special retention strategies as this will interfere with 
the overall study outcomes.
At discharge, the enrolled patients will be randomised 
to one of the three study arms described above. Study staff 
will prepare study packets, in sealed envelopes numbered 
consecutively. REDCap application will be used to 
randomly generate arm assignments to each packet. 
The assignment is independent of any patient factors, 
including whether the patient has access to a cell phone 
or lives in an area with cell phone coverage. In addition 
to the random arm assignment, the packet will include 
Table 1 Surgical site infection screening protocol
Question Answer
Have you had a fever since 
discharge?
Yes/no
At the incision, have you had 
increasing pain?
Yes/no
Any active drainage? Yes/no
  What colour is the fluid? Brown, yellow, green or 
white/red, pink, clear
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details on arm-specific follow-up such as follow-up plan 
for home visits (arm 1) or phone call date (arm 2). The 
packet will also include general discharge instructions 
including signs of a surgical site infection, how to contact 
study staff and how to return to a health centre for care or 
referral to KDH if an SSI is suspected by CHW.
All enrolled patients will be followed for 30 days postop-
eratively. If a patient is identified as having an SSI, she will 
be followed up to 90 days to document the progression 
and treatment of the infection. On POD 30, all patients 
will be called by a member of the study team to check in 
to see if they have returned to care. Study participants 
who return to care will be recorded by the register at 
the health facility where she presents (health centre or 
hospital), and the study team will have regular check-ins 
with the register to obtain the list of patients who returned 
to care. Clinical data from those follow-up visits will then 
be transcribed into REDCap for each patient.
data collection and variables
All study data will be collected, managed and store 
using REDCap electronic data capture tools hosted by 
Brigham and Women’s Hospital. REDCap is a secure web 
application that can support both online or offline data 
collection for research studies.21 22 The REDCap mobile 
application will be used by CHWs to administer the SSI 
screening protocol. There will be five distinct time points 
of data collection. Study coordinators will have access to 
data to evaluate for completeness.
First, on enrolment, all patients will provide basic demo-
graphics, socioeconomic and location data including but 
not limited to age, occupation, education, household 
income, insurance, home location, travel distance from 
the patient’s home, patient’s home village, cell, sector 
name, name of local CHW, phone number of the patient, 
phone number of a family member or a neighbour (in 
case the patient does not have personal phone), with 
permissions to call these numbers as part of follow-up. 
Second, on discharge, data collectors will complete a 
clinical chart review, extracting details on patient’s past 
medical history, intraoperative data (preoperative anti-
biotics, wound class, intraoperative complications) and 
postoperative care. Third, for patients in arm 1 and 
arm 2, we will collect the responses of the SSI screening 
protocol. The CHW will click on the patient’s ID number 
in REDCap, and the application will prompt the CHW to 
ask the three SSI screening protocol questions. The CHW 
will answer the questions on the tablet and the data will 
be stored. The fourth round will include the CHW sepa-
rately collecting data on process indicators related to the 
implementation of the intervention. For arm 1, these indi-
cators will include: ability to visit the patient on the sched-
uled date, ability to find the local CHW and the patient’s 
home, travel time, presence of the patient at time of 
visit, willingness of the patient to allow CHW into home, 
patient compliance with the SSI screening protocol, if the 
patient allowed the CHW to perform an examination/
take a photo of the wound and if there were any technical 
difficulties with the tablet or software. For arm 2, these 
indicators will include: whether the patient was reached 
by phone, how many attempts were made, which number 
was called and who answered, total call time and whether 
patient allowed the CHW to administer the SSI screening 
protocol. Finally, we will track the patient’s return to care 
within 30 days postoperatively using a register posted 
at each of the 16 district health centres where staff can 
record any study patients who present to that location 
for care. The head of maternity at each health centre 
will be a point person for this follow-up register. The 
study coordinator will call each point person to check 
if a C-section patient showed up at any health centre. If 
so, the study coordinator will visit the health centres that 
patients returned to. During the visit, the study coordi-
nator will refer to the follow-up register to record into 
REDCap which date the patient returned, wound status, 
diagnosis, treatment provided and if they were referred 
to KDH for further care. There will be a similar patient 
tracker log in the maternity ward reception at KDH to 
document patients referred to the hospital. This log will 
be completed by the reception nurse who will notify the 
study data collector who will input to REDCap. Finally, 
all patients with phone numbers provided will be called 
on POD 30 to inquire about any readmissions or visits to 
other healthcare facilities. Study staff will extract from the 
clinical chart the presence of an SSI, severity, treatment 
obtained, need for operative intervention, hospitalisation 
and/or complications.
Analyses
All analyses will be completed as intention to treat. For 
objective 1, the primary outcome is whether a patient 
returns to care at a health centre or district hospital with a 
provider-confirmed SSI. We will compare the proportion 
of patients who returned for follow-up with an SSI in arms 
1 and 2 with arm 3 using a two-sided, two-sample test of 
proportions at the α=0.05 significance level. The analyses 
assume that the rates of true SSIs are constant across the 
three arms, but that the proportion of these infections 
that return to care will vary across the study arms as a 
result of the intervention. We have purposely chosen not 
to trace patients to establish their true SSI status, as this 
would interfere with care seeking behaviour. However, 
we will perform a sensitivity analysis (changing the null 
hypothesis from p1=p2 to p1=kp2, where k reflects differ-
ences in SSI rates) to determine under what range of SSI 
rates the results are still valid. As a secondary outcome 
for objective 1, we will look at time to return-to-care for 
patients with SSI dichotomised as within 15 PODs or >15 
PODs. We will use a logistic regression model to assess the 
impact of study arm on timely return to care, controlling 
for potential confounders collected at enrolment. For 
objective 2, we will assess the implementation feasibility 
of the CHW-mHealth intervention by quantifying inter-
vention indicators. For each indicator, we will report 
the per cent of eligible encounters for which that step 
was successfully completed, and will categorise a specific 
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component as feasible if at least 85% of eligible counters 
have that step completed. For arms 1 and 2, we will calcu-
late a comprehensive feasibility measure that will assess 
the per cent of encounters that successfully implemented 
the full intervention, which we aim to achieve with at least 
85% of patient encounters.
Power calculation
Over the 12-month study period, we expect 78 patients per 
month or 1092 patients total to be eligible for inclusion. 
Assuming a 1-1-1 randomisation, 26 patients per month or 
364 patients total will be randomised to each arm (table 2).
We assume a constant SSI rate across the three arms 
of 15% (based on data from preliminary chart reviews 
prior to this study, and prior to the first phase of this study 
which identified the 10.3% prevalence over a 7-month 
enrolment window). We assume more patients with SSIs 
will return to care in arms 1 and 2 compared with arm 3 
(80% of SSIs in arms 1 and 2 compared with 40% in arm 
3). This corresponds to an overall return to care rate of 
12% in arms 1 and 2 and 6% in arm 3. We would have an 
81% power to detect a difference between the propor-
tion of patients that returned with an SSI in arms 1 and 2 
(12%) as compared with arm 3 (6%) with a two-sided test 
at the α=0.05 significance level.
Patient and public involvement
Patients and/or the public were not involved with the 
development of the research question or study design. 
The results of the study however will be disseminated at 
a community event at the hospital following the comple-
tion of the trial.
EthICs And dIssEMInAtIon
Study participants will be informed on the intent of the 
study, potential benefits and risks of their enrolment and 
how these will be minimised. Those who wish to enrol will 
be informed of their right to withdraw throughout the 
study period. All data collectors will sign confidentiality 
training and agreements; study coordinators and CHWs. 
Risks to privacy will be minimised by having all mobile 
devices and computers password protected. Data will be 
stored on a Health Insurance Portability and Account-
ability Act (HIPAA) compliant servers, and data will be 
deidentified prior to any analysis.
benefits, risks and limitations
The study does not alter the standard of care in any way 
and therefore there is minimal to no increased risk to the 
patient. Participants will likely benefit from this study in 
that the intervention we hypothesise will lead to a time-
lier diagnosis of SSI and will encourage patients to return 
to care, which is likely to correlate with improved health 
outcomes. However, one limitation of this study is that we 
do not measure health outcomes directly. Patients enrolled 
in both arms 1 and 2 will have additional contact with a 
healthcare provider (CHW) beyond the current standard 
of care. While not all participants may need this earlier 
screening, as not all will have surgical complications, the 
risks and discomforts associated with the screening are 
minimal. Given that patients will be randomised to all 
three arms, there is a risk of cross-contamination between 
patients from the same village. However, with our total 
sample size of 1200 patients, and that Kirehe District has 
approximately 612 villages with the population relatively 
evenly distributed, we do not expect more than two to five 
women per village to be enrolled. Since enrolment will be 
over 12 months, we expected that this contamination bias 
will be minimal.
On a systems level, this study will benefit the local 
providers and research staff to understand whether CHWs 
can be used in this capacity for postoperative follow-up. 
If we find that routine follow-up of patients with a CHW 
(either by phone or in-person visits) leads to a statistically 
significant higher identification of patients with an SSI, 
we will then be able to advocate for the use of CHWs for 
postoperative patients as that currently is not the stan-
dard. Furthermore, given the relationship that the study 
staff has with the CHW coordinator for Kirehe District, 
KDH, as well as the Ministry of Health, it could lead to 
a new standard of care for all patients to have regular 
follow-up after C-section. In addition, this study tracks 
feasibility indicators, which will inform broader conver-
sations about whether such follow-up is possible in this 
and similar contexts; this is particularly novel for the arm 
2, given that no programmes have used phone calls for 
postoperative follow-up in the rural areas in the region.
A potential risk will be decreasing the likelihood 
of a patient return to care when needed under the 
mHealth-CHW interventions. It is possible that the CHW 
will give the wrong SSI diagnosis or that a patient may 
delay return to care because of an expected visit from 
Table 2 Sample size calculation
Arm 1:
home visit+protocol
Arm 2:
phone call+protocol
Arm 3:
standard of care
Total patients 364 364 364
Anticipated SSIs 55 55 55
Hypothesised patients to return with SSIs 44 (80%) 44 (80%) 22 (40%)
Overall hypothesised proportion that will return with SSI 0.12 0.12 0.06
SSI, surgical site infection. 
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a CHW. This risk is moderate and will be monitored by 
a Data and Safety Monitoring Board (DSMB). Finally, 
a potential risk would be a breach in confidentiality, 
resulting in the disclosure of patient information. This 
risk is considered minimal as unique codes will be used 
in place of participant names throughout the study. Only 
principal investigators and study coordinators will have 
access to the final deidentified database.
data and safety Monitoring board
The DSMB will be designated to oversee the safety and 
effectiveness of the study. This committee will include 
one global surgery expert, one Rwandan health practi-
tioner and one statistician. Meetings of the DSMB will be 
held twice—once at the start of the study and 6 months 
after the start of phase II. At the first meeting, the DSMB 
will discuss the protocol, suggest modifications and estab-
lish guidelines to study monitoring by the Board.
At the second meeting, we will present the DSMB an 
interim analysis report, which will compare rates of return 
between the three study arms and include a list of adverse 
events of this study, if any. We anticipate half of the total 
cohort of patients will be included in this interim anal-
ysis. If the proportion who have returned in arms 1 and 
2 is significantly lower compared with standard of care, 
then the study will be stopped or one study arm will be 
dropped. Furthermore, if there are significantly more 
complex cases at return (higher rates of readmission or 
reoperation) in arms 1 or 2, then the study will be stopped 
or one study arm will be dropped. The outcome of the 
DSMB review will be summarised in a letter to the insti-
tutional review boards (IRBs) of all participating institu-
tions. A recommendation by the DSMB to terminate the 
study would be communicated to the National Institutes 
of Health Director, who will then accept or decline the 
recommendation.
Ethics approvals
The study has received IRB approval both in the USA and 
in Rwanda. Any proposed protocol amendments would 
undergo review and approvals by IRBs before further 
implementation.
dissemination
Results will be disseminated to the staff at KDH, the 
Rwanda Ministry of Health, including the electronic 
Health and CHW departments, the Rwanda Surgical 
Society and PIH. Results will also be disseminated at 
regional and international conferences and via peer-re-
viewed publications.
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